Urge your members of Congress to support continued medical research funding
Published on: September 01, 2017
The National Center for Advancing Translational Sciences (NCATS) released a request for information soliciting input on the use of viral vectors as platforms for therapeutic gene delivery to specific organs or cell types, and how such platforms might be developed most efficiently in clinical trials for the treatment of multiple diseases. Specifically, comments are requested in the following areas:
ASH members are encouraged to submit comments by Tuesday, September 19, 2017, in response to this request. To submit comments, email NCATSGTPlatformRFI@mail.nih.gov. For additional questions regarding this solicitation, please contact Dr. Philip John Brooks, Program Director in the Division of Clinical Innovation at NCATS.
Join the Grassroots Network to stay up to date on all of ASH’s Advocacy Campaigns.
Become an advocate for hematology with our easy-to-use advocacy resources.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology